Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Damora Therapeutics, Inc. (DMRA)

21.60 +0.11 (+0.51%)
At close: November 2 at 4:00:02 PM EST
21.60 0.00 (0.00%)
After hours: November 2 at 4:00:13 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
270,657
210,872
21,292
36,457
61,207
Operating Income
-270,657
-210,872
-21,292
-36,457
-61,207
Net Non Operating Interest Income Expense
8,172
1,167
844
1,689
722
Other Income Expense
0
-84
-950
-3,581
-1,139
Pretax Income
-262,485
-209,789
-21,398
-38,349
-61,624
Tax Provision
341
50
41
0
--
Net Income Common Stockholders
-262,826
-209,839
-21,439
-38,349
-61,624
Diluted NI Available to Com Stockholders
-262,826
-209,839
-21,439
-38,349
-61,624
Basic EPS
-0.26
-3.98
-18.53
-36.08
-60.75
Diluted EPS
-0.26
-3.98
-18.53
-36.08
-60.75
Basic Average Shares
24,426.84
1,363.01
1,157.15
1,062.87
1,016.36
Diluted Average Shares
24,426.84
1,363.01
1,157.15
1,062.87
1,016.36
Total Operating Income as Reported
-270,657
-210,872
-22,260
-39,905
-61,207
Total Expenses
270,657
210,872
21,292
36,457
61,207
Net Income from Continuing & Discontinued Operation
-262,826
-209,839
-21,439
-38,349
-61,624
Normalized Income
-262,826
-209,755
-20,489
-34,768
-60,485
Interest Income
8,172
1,167
844
1,689
722
Net Interest Income
8,172
1,167
844
1,689
722
EBIT
-270,657
-210,872
-21,292
-36,457
-61,207
EBITDA
-270,561
-210,838
-21,111
-35,627
-60,717
Reconciled Depreciation
96
34
181
830
490
Net Income from Continuing Operation Net Minority Interest
-262,826
-209,839
-21,439
-38,349
-61,624
Total Unusual Items Excluding Goodwill
0
-84
-950
-3,581
-1,139
Total Unusual Items
0
-84
-950
-3,581
-1,139
Normalized EBITDA
-270,561
-210,754
-20,161
-32,046
-59,578
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 10/29/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: